These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 31417866)

  • 21. Exploring the role of Mir204/211 in HNSCC by the combination of bioinformatic analysis of ceRNA and transcription factor regulation.
    Cai J; Yu Y; Xu Y; Liu H; Shou J; You L; Jiang H; Han X; Xie B; Han W
    Oral Oncol; 2019 Sep; 96():153-160. PubMed ID: 31422208
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Deep sequencing-based microRNA expression signatures in head and neck squamous cell carcinoma: dual strands of pre-miR-150 as antitumor miRNAs.
    Koshizuka K; Nohata N; Hanazawa T; Kikkawa N; Arai T; Okato A; Fukumoto I; Katada K; Okamoto Y; Seki N
    Oncotarget; 2017 May; 8(18):30288-30304. PubMed ID: 28415821
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comprehensive study of smoking-specific microRNA alterations in head and neck squamous cell carcinoma.
    Krishnan AR; Zheng H; Kwok JG; Qu Y; Zou AE; Korrapati A; Li PX; Califano JA; Hovell MF; Wang-Rodriguez J; Ongkeko WM
    Oral Oncol; 2017 Sep; 72():56-64. PubMed ID: 28797462
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bioinformatics Analysis of Prognostic miRNA Signature and Potential Critical Genes in Colon Cancer.
    Chen W; Gao C; Liu Y; Wen Y; Hong X; Huang Z
    Front Genet; 2020; 11():478. PubMed ID: 32582275
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Co-targeting of multiple microRNAs on factor-Inhibiting hypoxia-Inducible factor gene for the pathogenesis of head and neck carcinomas.
    Kao SY; Tsai MM; Wu CH; Chen JJ; Tseng SH; Lin SC; Chang KW
    Head Neck; 2016 Apr; 38(4):522-8. PubMed ID: 25351569
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of prognostic markers for hepatocellular carcinoma based on miRNA expression profiles.
    Wang X; Gao J; Zhou B; Xie J; Zhou G; Chen Y
    Life Sci; 2019 Sep; 232():116596. PubMed ID: 31233760
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prediction of radiotherapy response with a 5-microRNA signature-based nomogram in head and neck squamous cell carcinoma.
    Chen L; Wen Y; Zhang J; Sun W; Lui VWY; Wei Y; Chen F; Wen W
    Cancer Med; 2018 Mar; 7(3):726-735. PubMed ID: 29473326
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Screening of Target Genes and Regulatory Function of miRNAs as Prognostic Indicators for Prostate Cancer.
    Xiaoli Z; Yawei W; Lianna L; Haifeng L; Hui Z
    Med Sci Monit; 2015 Dec; 21():3748-59. PubMed ID: 26628405
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Five-microRNA Signature as Prognostic Biomarker in Colorectal Cancer by Bioinformatics Analysis.
    Yang G; Zhang Y; Yang J
    Front Oncol; 2019; 9():1207. PubMed ID: 31799184
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A nine-miRNA signature as a potential diagnostic marker for breast carcinoma: An integrated study of 1,110 cases.
    Xiong DD; Lv J; Wei KL; Feng ZB; Chen JT; Liu KC; Chen G; Luo DZ
    Oncol Rep; 2017 Jun; 37(6):3297-3304. PubMed ID: 28440475
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identifying Differentially Expressed MicroRNAs Between Cirrhotic and Non-Cirrhotic Hepatocellular Carcinoma and Exploring Their Functions Using Bioinformatic Analysis.
    Mei Y; You Y; Xia J; Gong JP; Wang YB
    Cell Physiol Biochem; 2018; 48(4):1443-1456. PubMed ID: 30064138
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identifying miRNA and gene modules of colon cancer associated with pathological stage by weighted gene co-expression network analysis.
    Zhou XG; Huang XL; Liang SY; Tang SM; Wu SK; Huang TT; Mo ZN; Wang QY
    Onco Targets Ther; 2018; 11():2815-2830. PubMed ID: 29844680
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of miR-499a-5p as a Potential Novel Biomarker for Risk Stratification in Endometrial Cancer.
    Ravegnini G; De Leo A; Coada C; Gorini F; de Biase D; Ceccarelli C; Dondi G; Tesei M; De Crescenzo E; Santini D; Corradini AG; Tallini G; Hrelia P; De Iaco P; Angelini S; Perrone AM
    Front Oncol; 2021; 11():757678. PubMed ID: 34804952
    [TBL] [Abstract][Full Text] [Related]  

  • 34. hsa-mir-3199-2 and hsa-mir-1293 as Novel Prognostic Biomarkers of Papillary Renal Cell Carcinoma by COX Ratio Risk Regression Model Screening.
    Luo W; Wang L; Luo MH; Huang YZ; Yang H; Zhou Y; Jia HT; Wang XX
    J Cell Biochem; 2017 Oct; 118(10):3488-3494. PubMed ID: 28338236
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased expression of miR-93 is associated with poor prognosis in head and neck squamous cell carcinoma.
    Li G; Ren S; Su Z; Liu C; Deng T; Huang D; Tian Y; Qiu Y; Liu Y
    Tumour Biol; 2015 May; 36(5):3949-56. PubMed ID: 25578493
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Uncovering the potential miRNAs and mRNAs in follicular variant of papillary thyroid carcinoma in the Cancer Genome Atlas database.
    Li M; Zhao B; Qu W; Zhang Z; Jiang Z
    Transl Cancer Res; 2019 Aug; 8(4):1158-1169. PubMed ID: 35116858
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum microRNA microarray analysis identifies miR-4429 and miR-4689 are potential diagnostic biomarkers for biliary atresia.
    Dong R; Shen Z; Zheng C; Chen G; Zheng S
    Sci Rep; 2016 Feb; 6():21084. PubMed ID: 26879603
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of prognostic microRNA candidates for head and neck squamous cell carcinoma.
    Hui L; Wu H; Yang N; Guo X; Jang X
    Oncol Rep; 2016 Jun; 35(6):3321-30. PubMed ID: 27035560
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Altered levels of miR-21, miR-125b-2*, miR-138, miR-155, miR-184, and miR-205 in oral squamous cell carcinoma and association with clinicopathological characteristics.
    Manikandan M; Deva Magendhra Rao AK; Rajkumar KS; Rajaraman R; Munirajan AK
    J Oral Pathol Med; 2015 Nov; 44(10):792-800. PubMed ID: 25482863
    [TBL] [Abstract][Full Text] [Related]  

  • 40. miR-96-5p targets PTEN expression affecting radio-chemosensitivity of HNSCC cells.
    Vahabi M; Pulito C; Sacconi A; Donzelli S; D'Andrea M; Manciocco V; Pellini R; Paci P; Sanguineti G; Strigari L; Spriano G; Muti P; Pandolfi PP; Strano S; Safarian S; Ganci F; Blandino G
    J Exp Clin Cancer Res; 2019 Mar; 38(1):141. PubMed ID: 30925916
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.